BioSpace News Archive

Drug Development

Rigel Pharma Awaits FDA Approval for Tavalisse, Builds Commercial Org for Drug Launch

The U.S. Food and Drug Administration is set to rule on Tavalisse (fostamatinib disodium), an oral spleen tyrosine kinase (SYK) inhibitor, for adult patients with chronic or persistent immune thrombocytopenia (ITP) on April 17.

January 12, 2018
·
3 min read
·
Alex Keown
Business

Athenex Moves Forward With $205M New York Plant

According to a SEC filing, the cost of the facility will be paid in part by the State of New York.

January 12, 2018
·
1 min read
Business

AbbVie to Host Fourth-Quarter 2017 Earnings Conference Call

AbbVie will announce its fourth-quarter 2017 financial results on Friday, Jan. 26, 2018, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time.

January 12, 2018
·
1 min read
Pharm Country

Bard Cancer Diagnostics: Global Recognition for Advanced Imaging and Early Detection

Today’s Bard Cancer Diagnostics continues the original blueprint of using cutting edge imaging solutions such as the 3D Doppler Histogram Analysis technology and other innovations to battle cancer.

January 12, 2018
·
3 min read
Planmeca Emerald and Planmeca PlanScan Intraoral Scanners Accepted by Orchestrate 3D System

Orchestrate 3D provides treatment planning software and 3D printing solutions that allow orthodontists to design and create clear aligners and other orthodontic appliances.

January 12, 2018
·
2 min read
DBV Technologies : Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company - Jan. 12, 2018

Total net* of voting rights: 24, 985, 883.

January 12, 2018
·
1 min read
Business

Abiomed Third Quarter Fiscal 2018 Earnings and Conference Call Notification

The Company will host a conference call to discuss the results on Thursday, February 1, 2018, at 8:00 a.m. EST.

January 12, 2018
·
2 min read
Lone Star Bio

Rice University Release: Fed Grant Will Help Unlock Embryonic Secrets

The work will build upon Warmflash’s research into human embryonic development and the mechanisms by which nearly identical cells morph over time into the hundreds of types that become a mature organism.

January 12, 2018
·
4 min read
Pharm Country

It’s a Girl! - Laerdal Medical Announces New SimNewB and SimBaby Simulators

Always committed to improvement, Laerdal Medical will launch the new SimNewB and SimBaby simulators tomorrow at the IMSH conference in Los Angeles, CA.

January 12, 2018
·
2 min read
Deals

Aviragen Board Of Directors Unanimously Recommends That Stockholders Vote FOR The Proposed Merger With Vaxart

The Company notes that the transaction maximizes the value of Aviragen.

January 12, 2018
·
10 min read